{"prompt": "['B. Braun Medical Inc.', 'OPM-G-H-1506', 'Prontosan', 'Protocol Amendment 2', '9', 'STUDY PROCEDURES', 'Table 1 outlines the timing of assessments to be performed throughout the study. See', 'Sections 10 and 11 for additional details of study procedures.', '14 November 2018', 'Page 34']['B. Braun Medical Inc.', 'OPM-G-H-1506', 'Prontosan', 'Protocol Amendment 2', 'Table 1 Schedule of Assessments', 'Treatment Period', 'Period', 'Screening', 'Final Visit', 'Visit', '(End of', 'Baseline Visit', 'Treatment)', 'Week 1 (1 week', 'Week 2', 'Week 3', 'Week 4', 'Week 5', 'Week', 'Week 0', '1 day after', '(1 day)', '(1 day)', '(1 day)', '(+1 day)', 'screening)', 'Visit', '1', '2', '3', 'At home', 'At home', '4', 'Informed Consent', 'X', 'Demographics', 'X', 'Inclusion/Exclusion Criteria', 'X', 'X', 'Medical History/ Wound History', 'X', 'X', 'Concomitant Medication Review', 'X', 'X', 'X', 'X', 'X', 'X', 'Vital Signst', 'X', 'X', 'Physical Examination', 'X', 'Brief Physical Examination', 'X', 'Collect Blood for Clinical Laboratory Tests', 'Xc', 'X', 'Wound-QoL Questionnaired', 'X', 'X', 'X', 'X', 'X', 'X', 'Wound Assessmente', 'X', 'X', 'X', 'X', 'Measure Wound(s) Size Using Study Rulers', 'X', 'XI', 'Xf', 'XI', 'Photograph Wound(s) Using Study Camera', 'XI', 'XI', 'XI', 'Dispense Diarys', 'X', 'X', 'Collect/Review Diary', 'X', 'X', 'Administer Study Treatment h', 'X', 'X', 'X', 'X', 'X', 'Provide/Review Instructions on Treatment and Diary8', 'X', 'X', 'Dispense Study Treatment', 'X', 'X', 'Perform Study Treatment Accountability', 'X', 'X', '14 November 2018', 'Page 35']['B. Braun Medical Inc.', 'OPM-G-H-1506', 'Prontosan', 'Protocol Amendment 2', 'Treatment Period', 'Screening', 'Period', 'Final Visit', 'Visit', '(End of', 'Baseline Visit', 'Treatment)', 'Week 1 (1 week', 'Week 2', 'Week 3', 'Week 4', 'Week 5', 'Week', 'Week 0', '1 day after', '(1 day)', '(1 day)', '(+1 day)', '(1 day)', 'screening)', 'Visit', '1', '2', '3', 'At home', 'At home', '4', 'Adverse Event Assessment', 'X', 'X', 'X', 'X', 'X', 'Abbreviations: AE=adverse event; IFU=Instructions for Use; Wound-QoL=Wound Quality of Life', 'early discontinuation visit.', 'bVital sign measurements will be performed at screening and at the Week 5 (end of treatment or early discontinuation) visit.', 'CAt screening, clinical laboratory tests will be done only if results from tests performed within 1 month prior to screening are not available. Tests include', 'standard hematology and serum chemistry, plus glycated hemoglobin.', 'daptients must complete the Wound-QoL questionnaire before any other study-related procedure, including any dressing change (with the exception of', 'consenting the patient at screening). Patients will be given several blank Wound-QoL questionnaires at the Week 2 visit to fill out on specific', 'dates', 'during', 'Weeks 3 and 4 (on the same day each week); study site personnel will call the patient on these dates to remind them to fill out the questionnaires prior to', 'study treatment on those dates.', 'The Investigator or designee will assess the wound(s) for appearance, granulation tissue, exudate, drainage, surrounding erythema and/or swelling, and any', 'signs of infection.', 'To be done pre-cleaning and post-cleaning.', '8A diary and sufficient study treatment to use until the next visit will be dispensed to patients. Instructions on administering study treatment, recording', 'treatment dates and times and any reactions to treatment in the diary will be explained to the patient and/or caregiver.', 'solution and Prontosan gel will be administered by the Investigator or designee at each clinic visit. At home, patients or their caregivers will', \"administer Prontosan solution and Prontosan gel. Each patient's treatment regimen will be given per the institutional guidelines and the Prontosan IFU.\", 'At home, AEs are collected in the patient diary. In the clinic, patients are assessed for AEs by the Investigator.', '14 November 2018', 'Page 36']\n\n###\n\n", "completion": "END"}